
All patients with colorectal cancer being considered for treatment with the EGFR inhibitors cetuximab and panitumumab should undergo extended RAS mutational testing to predict their response to the drugs.

Your AI-Trained Oncology Knowledge Connection!


All patients with colorectal cancer being considered for treatment with the EGFR inhibitors cetuximab and panitumumab should undergo extended RAS mutational testing to predict their response to the drugs.

Insurance plans that limit which doctors have in-network status have become a mainstay of healthcare, helping keep costs down but stoking concerns and complaints from hospital administrators and regulators about patients' access to care.

Edward Cancer Center is eagerly hoping to be selected to participate in the Centers for Medicare & Medicaid Services' new Oncology Care Model, a pilot program that will require the cancer center to measurably cut costs even as it beefs up its services and analytical capabilities.

The array of services and opportunities with which Florida Cancer Specialists & Research Institute provides its physicians, while still allowing them a high degree of autonomy, has proved a powerful draw since the group was founded as a solo practice by William Harwin, MD, in 1984.

The growing popularity of high-deductible health insurance plans has created a range of increasing pressures on oncologists and hematologists.